JDQ443,tislelizumab
Novartis,Beigene
['kontrast-01', 'jdq443', 'sclc', 'lung', 'lcsm,(-blcsm)', 'solid tumor', 'nsclc']
kontrast-01 update: safety and efficacy of jdq443 in kras g12c-mutated solid tumors including non-small cell lung cancer (nsclc) #asco23 #lcsm 
Medical Oncology 🏥 Hospital General Universitario Gregorio Marañón⎪@myESMO Faculty 🫁 ⎪Power to the patients #endlungcancer #lcsm